Table 1 Baseline characteristics of the study population
Baseline Characteristics | N (%) |
|---|---|
Male | 6 (40) |
Female | 9 (60) |
Age, years | |
< 10 | 2 (13) |
10–30 | 8 (53) |
30–50 | 4 (27) |
> 50 | 1 (7) |
Pathology | |
Vitelliform macular dystrophy | 5 (29) |
PXE | 2 (12) |
MFC | 2 (12) |
Laser pointer injury | 2 (12) |
PIC | 2 (12) |
MacTel type II | 1 (6) |
Stargardt disease | 1 (6) |
Sorsby macular dystrophy | 1 (6) |
Juvenile X-linked foveoschisis | 1 (6) |
Mean baseline BCVA (decimal) | |
0.1 | 10 (59) |
> 0.1–0.32 | 7 (41) |
Number of IVA injections | |
1 | 6 (35) |
2–5 | 9 (53) |
> 5 | 2 (12) |
Follow-up period (months) | |
< 12 | 10 (59) |
12–24 | 4 (23.5) |
> 24 | 3 (18) |